J Neurogastroenterol Motil.  2020 Jul;26(3):299-310. 10.5056/jnm20107.

The Practice of Gastrointestinal Motility Laboratory During COVID-19 Pandemic: Position Statements of the Asian Neurogastroenterology and Motility Association (ANMA-GML-COVID-19 Position Statements)

  • 1Department of Medicine, Yong Loo Lin School of Medicine, The National University of Singapore, Singapore
  • 2Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore
  • 3Department of Gastroenterology, Sheikh Russel National Gastroliver Institute and Hospital, Dhaka, Bangladesh
  • 4Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore
  • 5Duke-NUS Medical School, Singapore
  • 6School of Medical Sciences, Universiti Sains Malaysia, Malaysia
  • 7St George and Sutherland Clinical School, University of New South Wales, Kogarah, NSW, Australia
  • 8Department of Gastroenterology and Hepatology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
  • 9Department of Gastroenterology, GB Pant Hospital, New Delhi, India
  • 10Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
  • 11Endoscopy center for Diagnosis of Treatment, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
  • 12Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan
  • 13Center of Excellence in Neurogastroenterology and Motility, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
  • 14Division of Gastroenterology, Department of Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
  • 15Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
  • 16Dayanand Medical College & Hospital, Ludhiana, Punjab, India
  • 17Saw Swee Hock School of Public Health, NUS, Singapore
  • 18Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
  • 19Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
  • 20Department of Medicine, University of Malaysia, Kuala Lumpur, Malaysia
  • 21Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea
  • 22Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
  • 23Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute Medical Science, Lucknow, India


During the Coronavirus Disease 2019 (COVID-19) pandemic, practices of gastrointestinal procedures within the digestive tract require special precautions due to the risk of contraction of severe acute respiratoy syndrome coronavirus-2 (SARS-CoV-2) infection. Many procedures in the gastrointestinal motility laboratory may be considered moderate to high-risk for viral transmission. Healthcare staff working in gastrointestinal motility laboratories are frequently exposed to splashes, air droplets, mucus, or saliva during the procedures. Moreover, some are aerosol-generating and thus have a high risk of viral transmission. There are multiple guidelines on the practices of gastrointestinal endoscopy during this pandemic. However, such guidelines are still lacking and urgently needed for the practice of gastrointestinal motility laboratories. Hence, the Asian Neurogastroenterology and Motility Association had organized a group of gastrointestinal motility experts and infectious disease specialists to produce a position statement paper based-on current available evidence and consensus opinion with aims to provide a clear guidance on the practices of gastrointestinal motility laboratories during the COVID-19 pandemic. This guideline covers a wide range of topics on gastrointestinal motility activities from scheduling a motility test, the precautions at different steps of the procedure to disinfection for the safety and well-being of the patients and the healthcare workers. These practices may vary in different countries depending on the stages of the pandemic, local or institutional policy, and the availability of healthcare resources. This guideline is useful when the transmission rate of SARS-CoV-2 is high. It may change rapidly depending on the situation of the epidemic and when new evidence becomes available.


COVID-19; Esophageal motility disorders; Gastrointestinal diseases; Gastrointestinal motility; Infection control
Full Text Links
  • JNM
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr